These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1071665)

  • 1. Serum dopamine beta-hydroxylase activity in essential hypertension.
    Aoki K; Tazumi K; Yoshida T; Kato S; Sato I; Takikawa K
    Clin Sci Mol Med Suppl; 1976 Dec; 3():465S-467S. PubMed ID: 1071665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum dopamine-beta-hydroxylase activity in essential hypertension and in chronic renal failure with hypertension.
    Aoki K; Tazumi K; Takikawa K
    Jpn Circ J; 1975 Oct; 39(10):1111-4. PubMed ID: 1195506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dopamine-beta-hydroxylase after treatment with beta-blockers in hypertension.
    Aberg H; Hedstrand H; Wetterberg L; Ross SB
    Int J Clin Pharmacol Biopharm; 1975 Jan; 11(1):15-8. PubMed ID: 1150360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Plasma dopamine beta-hydroxylase activity in hypertension treated with adrenergic beta receptor blockaders].
    Merkulova NK
    Ter Arkh; 1981; 53(1):69-72. PubMed ID: 7221913
    [No Abstract]   [Full Text] [Related]  

  • 5. The effects of therapy for mild hypertension on circulating level of dopamine beta-hydroxylase.
    Grant C; Routh JI; Lawton W; Witte DL
    Clin Chim Acta; 1976 Jun; 69(2):333-40. PubMed ID: 1277563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum dopamine-beta-hydroxylase activity in a new strain of spontaneously hypertensive rats.
    Affara S; Denoroy L; Renaud B; Vincent M; Sassard J
    Experientia; 1980 Oct; 36(10):1207-8. PubMed ID: 7418806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of catecholamine concentrations and dopamine-beta-hydroxylase activities in plasma from normotensive subjects and from patients with essential hypertension at rest and during exercise.
    Planz G; Gierlichs HW; Hawlina A; Planz R; Stephany W; Rahn KH
    Klin Wochenschr; 1976 Jun; 54(12):561-9. PubMed ID: 940292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of correlation of plasma norepinephrine and dopamine-beta-hydroxylase in hypertensive and normotensive subjects.
    Lake CR; Ziegler MG; Coleman M; Kopin IJ
    Circ Res; 1977 Dec; 41(6):865-9. PubMed ID: 923037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The evaluation of plasma dopamine beta-hydroxylase activity in essential and secondary hypertension.
    Iseki F; Kuchii M; Nishio I; Masuyama Y
    Jpn Heart J; 1979 May; 20(3):307-20. PubMed ID: 572440
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine-beta-hydroxylase activity and catecholamine concentrations in plasma: experimental and essential hypertension.
    Grobecker H; Saavedra JM; McCarty R; Chiueh CC; Kopin IJ
    Postgrad Med J; 1977; 53 Suppl 3():43-8. PubMed ID: 928266
    [No Abstract]   [Full Text] [Related]  

  • 11. The role of serum dopamine-beta-hydroxylase in essential hypertension.
    Yashima O; Ozawa M; Sato M; Suzuki K; Kimura T
    Jpn Circ J; 1974 Dec; 38(12):1085-8. PubMed ID: 4436937
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum dopamine-beta-hydroxylase: constancy of levels in normotensive adults and decreases with development of blood pressure elevation.
    Lamprecht F; Andres R; Kopin KJ
    Life Sci; 1975 Sep; 17(5):749-54. PubMed ID: 1207393
    [No Abstract]   [Full Text] [Related]  

  • 13. The meaning of dopamine beta-hydroxylase in essential hypertension.
    Alexandre JM; London GM; Chevillard C; Lemaire P; Safar ME; Weiss Y
    Clin Sci Mol Med; 1975 Dec; 49(6):573-9. PubMed ID: 1204288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies on the effects of propanolol on plasma catecholamine levels in patients with essential hypertension.
    Rahn KH; Gierlichs HW; Planz G; Planz R; Schols M; Stephany W
    Eur J Clin Invest; 1978 Jun; 8(3):143-8. PubMed ID: 99311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine beta-hydroxylase immunoreactivity in human cerebrospinal fluid: properties, relationship to central noradrenergic neuronal activity and variation in Parkinson's disease and congenital dopamine beta-hydroxylase deficiency.
    O'Connor DT; Cervenka JH; Stone RA; Levine GL; Parmer RJ; Franco-Bourland RE; Madrazo I; Langlais PJ; Robertson D; Biaggioni I
    Clin Sci (Lond); 1994 Feb; 86(2):149-58. PubMed ID: 8143425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma dopamine beta-hydroxylase: a possible aid in the study and evaluation of hypertension.
    Schanberg SM; Stone RA; Kirshner N; Gunnells JC; Robinson RR
    Science; 1974 Feb; 183(4124):523-5. PubMed ID: 4809562
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between serum dopamine-beta-hydroxylase activity and blood pressure in middle-aged men.
    Huttunen JK; Pispa J; Kumlin T; Mattila S; Naukkarinen V; Miettinen T
    Hypertension; 1979; 1(1):47-52. PubMed ID: 544513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Proceedings: Clinical significance of serum DBH (dopamine-beta-hydroxylase) activity in essential hypertension].
    Aoki H; Tasumi K; Tomita N; Shimazaki H; Kato S
    Nihon Naibunpi Gakkai Zasshi; 1974 Feb; 50(2):531. PubMed ID: 4476554
    [No Abstract]   [Full Text] [Related]  

  • 19. [Study on Dopamine-beta-hydroxylase activity in serum in patients with essential hypertension at rest and during exercise (author's transl)].
    Doijiri K
    Nihon Naibunpi Gakkai Zasshi; 1979 May; 55(5):710-9. PubMed ID: 467741
    [No Abstract]   [Full Text] [Related]  

  • 20. Proceedings: Serum dopamine beta-hydroxylase activity in developing spontaneously hypertensive rats and the effect of salt administration.
    Nagatsu T; Kato T; Numata Y; Ikuta K; Umezawa H
    Jpn Heart J; 1975 May; 16(3):324-5. PubMed ID: 1160171
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.